DocG DocG | AI-Powered Clinical Summaries
← DocG Medical Summaries

Top Family Medicine / General Practice / Primary Care Research Papers

Live ranking — trailing 6 months, each paper's latest score Scores fold Primary-Care Relevance & Applicability into the quality dimensions; papers scored before the dynamic-specialty rubric keep their original score Showing the top 10 of 682 ranked articles — sign in free for the full ranking and per-criterion score breakdowns
1. 8.3
Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults.
Overall: This rigorous, large trial shows that atorvastatin moderately reduces major cardiovascular events in healthy older adults without extending disability-free survival, offering directly actionable evidence for US preventive care.
2. 8.0
Sustained benefit of compression therapy for preventing recurrent leg cellulitis: extended follow-up of a randomised controlled trial.
Overall: This small but well-conducted randomized trial found a large, durable reduction in recurrent cellulitis and hospitalization with a practical intervention, though its open-label single-center design and unreported harms limit certainty.
3. 8.0
Effectiveness of Nirmatrelvir/Ritonavir for Outpatients in the Era of Omicron, Vaccination, and Previous Infection: A Meta-analysis.
Overall: This large contemporary meta-analysis supports meaningful reductions in hospitalization and death with nirmatrelvir-ritonavir among higher-risk outpatients, although reliance on observational studies and absent harm data limit certainty.
4. 7.9
Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis.
Overall: This rigorous, highly applicable meta-analysis shows that routine calcium or vitamin D supplementation offers little to no fracture or fall prevention benefit for most community-dwelling adults.
5. 7.8
Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.
Overall: This well-conducted US observational analysis provides precise, clinically meaningful reassurance about the short-term safety and practical use of same-day COVID-19 and influenza vaccination, while residual confounding and absent absolute risks limit certainty.
6. 7.8
A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trials.
Overall: A large and precise randomized-trial meta-analysis demonstrates early, modest reductions in major cardiovascular events from blood-pressure lowering, with high primary-care relevance but limited novelty and no reported harms.
7. 7.7
Spinal Manipulation and Clinician-Supported Self-Management for Preventing Chronic Low Back Pain Impact: The PACBACK Randomized Clinical Trial.
Overall: This large, well-retained US randomized trial found clinically meaningful responder and activity-interference benefits from supported self-management despite a small average effect and unreported harms.
8. 7.7
Efficacy and harms of polypills for cardiovascular disease prevention: A systematic review and meta-analysis of randomized controlled trials.
Overall: This large randomized-trial meta-analysis addresses a common primary-care decision and suggests clinically important cardiovascular benefits, although absolute benefit, mortality impact, harms, and practical US implementation remain insufficiently defined.
9. 7.7
Alcohol use: less is better. An umbrella systematic review of clinical interventions, policies, and dose-response health risks in adults.
Overall: This rigorous umbrella review is highly relevant to routine alcohol counseling and supports a simple lower-consumption message, but the demonstrated intervention effect is modest and direct clinical benefit remains insufficiently quantified.
10. 7.6
Impact of treatment duration on the effectiveness of opioid analgesia: a systematic review and meta-analysis.
Overall: This randomized-trial meta-analysis addresses clinically meaningful pain outcomes and has a clear implication against prolonged opioid therapy, but missing quantitative results and limitations of cross-duration subgroup comparisons weaken certainty.
Score Guide: 9-10 Exceptional 7-8 Strong 5-6 Moderate 3-4 Weak 1-2 Poor

Get the top Family Medicine / General Practice / Primary Care papers in your inbox

Free 300-word clinical summaries 3× per week, plus the full ranking of all 682 recent Family Medicine / General Practice / Primary Care papers with per-criterion AI score breakdowns.

Sign Up Free